Seoul National University Hospital has recently unveiled a clinical decision support system for precision medicine treatment.WHY IT MATTERS
The SNUH POLARIS (Precision Oncology and Rare-Common Disease Supporter) is said to be the first of its…
What You Should Know:
– Mission Bio, a leader in single-cell multiomics solutions for precision medicine, today announced the launch of its Single-Cell Genotype and Targeted Gene Expression assay, expanding the capabilities of its Tapestri Platform…
Continue Reading
What You Should Know:
– Oxford Cancer Biomarkers Ltd (OCB), a leader in molecular precision cancer diagnostic tests, has today announced a new partnership with Mira Precision Health Inc.
– This collaboration aims to advance OCB’s…
Continue Reading
Spesana logo
What You Should Know:
– Aranscia, a global provider of award-winning clinical workflow and diagnostic technology solutions announced its strategic acquisition of Spesana and its best-in-class suite of patient navigation, clinical collaboration, and oncology…
Continue Reading
What You Should Know:
– ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI’s Translational360™ and AI SaaS solutions, which use artificial intelligence and machine learning (AI/ML)-derived insights to accelerate clinical development in precision…
Continue Reading
Healthcare data company ConcertAI announced a multi-year agreement with pharmaceutical and biotechnology giant Bayer to utilize ConcertAI’s Translational360 and AI SaaS offerings.The offerings use AI and machine learning-acquired insights to speed up clinical development…
Continue Reading
What You Should Know:
– Frederick Health (Frederick, MD) recently launched a first-of-its-kind precision medicine integration that enhances their decision support capabilities with intuitive recommendations that are tailored to the individual patient and their cancer’s specific…
Continue Reading
The confluence of new technologies with artificial intelligence (AI) and machine learning (ML) analytical techniques is rapidly advancing the field of precision oncology, promising to improve diagnostic approaches and therapeutic strategies for patients with…
Continue Reading
Revolutionary Healthcare Partnership Announced
GE HealthCare Technologies Inc. and the University of California San Francisco’s Department of Radiology and Biomedical Imaging have joined forces in a landmark partnership focusing on advanced imaging and precision oncology…
Groundbreaking AI Study Transforms Cancer Diagnostics
Lunit, in partnership with Japan’s National Cancer Center Hospital East (NCCHE), has published breakthrough research in the Journal of Clinical Oncology Precision Oncology. Their study demonstrates how AI-powered pathology…
